[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Blue Earth Diagnostics
Blue Earth Diagnostics
Myeloid Therapeutics
Incyte Corporation
Novartis
MacroGenics
Nurix Therapeutics, Inc.
Guardant Health, Inc.
Bicara Therapeutics
Xencor, Inc.
858 Therapeutics, Inc.
Toray Industries, Inc
Context Therapeutics Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Medicenna Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Exelixis
Pfizer
Stanford University
Cybrexa Therapeutics
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
Nerviano Medical Sciences
Hoffmann-La Roche
University Hospital, Geneva
Eli Lilly and Company
BioEclipse Therapeutics
Sheba Medical Center
Eastern Cooperative Oncology Group
Xencor, Inc.
Ohio State University Comprehensive Cancer Center
Corcept Therapeutics
MacroGenics
Karolinska University Hospital
Gilead Sciences
National University Hospital, Singapore
AIDS Malignancy Consortium
Abramson Cancer Center at Penn Medicine
Canadian Cancer Trials Group
City of Hope Medical Center
Swiss Cancer Institute
Mitra RxDx, Inc.
Pfizer
Wake Forest University Health Sciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
University of Arizona